Related Experiment Video
Updated: Jan 8, 2026

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
Published on: February 14, 2025
Decrease in Psoas Muscle Mass and Density Following Liver Transplantation Is Greatest in Patients With the Highest
Michael G Megaly1, William C Miller1,2, Jessica Thul3
1Division of Solid Organ Transplantation, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Liver transplantation (LT) can lead to sarcopenia, a loss of muscle mass and density. Patients with higher initial muscle mass experienced the greatest declines post-transplant, suggesting multifactorial influences on muscle changes after LT.
Area of Science:
- Hepatology
- Transplantation Surgery
- Radiology
- Geriatrics
Background:
- Sarcopenia is a significant predictor of morbidity and mortality in liver transplant (LT) recipients.
- Psoas muscle area (PAI) and mean Hounsfield units (mHU) are key CT-derived metrics for assessing sarcopenia.
- Limited data exists on psoas muscle changes pre- and post-LT.
Purpose of the Study:
- To investigate changes in psoas muscle area and density before and after liver transplantation.
- To analyze the impact of pre-transplant sarcopenia severity on post-transplant muscle changes.
Main Methods:
- Retrospective analysis of pre- and post-transplant CT scans from 104 adult liver transplant recipients.
- Quantification of Psoas Area Index (PAI) and mean Hounsfield units (mHU) for muscle mass and density.
- Stratification of results by pre-transplant PAI quartiles.
Main Results:
- Overall decrease in PAI (12%) and mHU (7%) post-LT.
- The most significant reductions in PAI (-15%) and mHU (-15%) were observed in patients with the highest baseline muscle mass and density.
- No correlation found between PAI and mHU changes.
Conclusions:
- Liver transplantation is associated with decreased psoas muscle mass and density.
- Patients with higher baseline muscle mass experience the most substantial muscle loss post-transplant.
- Muscle changes post-LT are influenced by multiple factors, warranting further investigation.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

